1/39
Vocabulary practice flashcards covering medical genetics, mechanisms of gene expression regulation, population genetics, cancer genomics, functional variations, and multifactorial complex diseases.
Gene Expression
The biological process of decoding information from a gene into a functional product, which can be either a functional protein or a non-coding RNA molecule.
Housekeeping Genes
Genes that are constitutively expressed in virtually all cells of an organism because their encoded products are necessary for basal, essential cellular operations (e.g., β-actin [ACTB], ribosomal protein genes, and ubiquitin C [UBC]).

Nucleosome
The fundamental repeating structural unit of eukaryotic chromatin, consisting of 146 or 147 base pairs of DNA wrapped around an octamer core of eight histone proteins (two each of H2A, H2B, H3, and H4).
Euchromatin
A decondensed, open chromatin state that permits access to RNA polymerase and transcription factors, corresponding to transcriptionally active genomic regions.
Heterochromatin
A densely packed, highly condensed chromatin configuration that restricts access to the transcriptional machinery, rendering the underlying DNA transcriptionally silent.
DNA Methylation
An epigenetic modification catalyzed by DNA methyltransferases that covalently attaches a methyl group to the 5-carbon of cytosine bases in CpG dinucleotides, typically promoting chromatin compaction and gene silencing.
Histone Acetylation
A post-translational epigenetic modification catalyzed by histone acetyltransferases (HAT) that transfers acetyl groups to basic histone tails, neutralizing their positive charge to establish an open chromatin configuration that permits transcription.
Promoter
A core cis-acting DNA regulatory region immediately upstream of the transcription start site that functions as an on/off switch where RNA polymerase and general transcription factors (such as TFIID) assemble to initiate transcription.
Enhancer
A cis-acting DNA regulatory element that can reside distally from a target gene and acts to increase the rate or volume of transcription, often requiring physical DNA looping to interact directly with the promoter complex.
Trans-Acting Factors
Diffusible molecules (such as protein transcription factors or regulatory RNAs) encoded by distant genomic loci that bind to specific cis-acting DNA elements to modulate gene expression.
Alternative Splicing
A post-transcriptional mechanism in which exons of a precursor mRNA are differentially selected, combined, or skipped, enabling a single primary gene sequence to generate multiple distinct protein isoforms.
RNA-Induced Silencing Complex (RISC)
A cytoplasmic multiprotein and ribonucleic acid complex guided by microRNAs (miRNAs) or short interfering RNAs (siRNAs) to bind complementary mRNA transcripts and execute translational repression or mRNA degradation.
Ubiquitination
A post-translational regulatory modification wherein ubiquitin polypeptides are covalently attached to a protein, targeting it for rapid destruction by the proteasome.
Somatic Recombination
A somatic gene rearrangement mechanism occurring in developing lymphocytes that assembles distinct Variable (V), Diversity (D), and Joining (J) gene segments to produce up to 1030 unique antibody and T-cell receptor binding specificities.
Major Histocompatibility Complex (MHC / HLA)
A highly polymorphic gene complex located on chromosome 6p21.31 encoding cell-surface Class I and Class II glycoproteins that display peptide antigens to T-cell receptors to differentiate self from foreign entities.

Hardy-Weinberg Equilibrium (HWE)
A foundational population genetics principle stating that allele and genotype frequencies remain constant across generations in a non-evolving population, mathematically described by the equations p+q=1 and p2+2pq+q2=1.
Genetic Drift
Unpredictable fluctuations in allele frequencies from one generation to the next attributable strictly to chance and random sampling of gametes, having the most pronounced effects in small populations.
Bottleneck Effect
A sharp reduction in population size caused by sudden environmental catastrophes or demographic events (e.g., natural disasters, famine, or war) that randomly distorts allele frequencies in the surviving population.
Founder Effect
A form of genetic drift that occurs when a small subpopulation establishes a new geographic colony, restricting total genetic variation and causing rare alleles to reach high frequencies (e.g., Ellis-van Creveld syndrome in the Pennsylvania Amish).
Heterozygote Advantage
A form of balancing selection in which heterozygous individuals (Aa) exhibit greater reproductive fitness than either homozygote (AA or aa), thereby maintaining deleterious disease alleles in the gene pool (e.g., sickle cell trait providing protection against malaria).
Haplosufficiency
A genetic condition in which a single functional copy of a gene produces sufficient product (∼50% of normal levels) to support a standard, healthy wild-type phenotype, rendering loss-of-function mutations recessive.
Haploinsufficiency
A condition in which one wild-type allele is insufficient to maintain normal physiological function (50% protein output is inadequate), resulting in a dominant disease phenotype from a heterozygous loss-of-function mutation (e.g., Familial Hypercholesterolemia via the LDLR gene).
Gain-of-Function (GoF) Mutation
A mutation that confers excessive, constitutive, or novel activity onto a gene product ("the stuck accelerator"), typically manifesting as an autosomal dominant phenotype (e.g., FGFR3 constitutive activation in achondroplasia).
Dominant-Negative Mutation
A mutation encoding an altered protein ("the saboteur") that is structurally defective and directly disrupts or poisons the activity of the wild-type protein produced from the normal allele in a multiprotein complex (e.g., defective collagen chains in osteogenesis imperfecta).
Anticipation
A genetic phenomenon seen in dynamic short tandem repeat (STR) expansion disorders where a disease exhibits progressively earlier age of onset and increasing clinical severity across successive generations.
Genomic Imprinting
An epigenetic process where parent-specific DNA methylation during gametogenesis permanently silences either the maternal or paternal allele, leaving the somatic cell functionally hemizygous for that gene locus.
Uniparental Disomy (UPD)
A cytogenetic circumstance in which a diploid individual inherits both homologues of a chromosome pair from a single parent and none from the other parent, often precipitating disease when the involved chromosome carries imprinted clusters.
Driver Mutation
A genetic alteration that confers a distinct growth, proliferative, or survival advantage to a somatic cell lineage, driving clonal expansion and the multi-step progression toward malignancy.

Knudson's Two-Hit Hypothesis
The oncogenetic paradigm asserting that tumorigenesis at a tumor suppressor locus necessitates the biallelic inactivation of both copies; hereditary cases inherit one germline mutation across all cells and require only one somatic hit to transform.
Gatekeeper Genes
A category of tumor suppressor genes whose encoded proteins directly govern and brake cell cycle progression or enforce apoptosis to curtail cell proliferation (e.g., RB1, TP53, APC).
Caretaker Genes
A functional class of tumor suppressor genes responsible for preserving genomic stability and executing DNA repair pathways to indirectly restrain neoplasia (e.g., BRCA1, BRCA2, MLH1, MSH2).
Proto-Oncogene
A normal cellular gene involved in signaling pathways that stimulate cell division, growth, and survival; gain-of-function somatic alterations convert it into a cancer-promoting oncogene.

Philadelphia Chromosome
A truncated translocation chromosome generated by reciprocal exchange between chromosomes 9 and 22 (t(9;22)(q34;q11)), producing an abnormal BCR-ABL1 fusion protein with constitutive tyrosine kinase activity in chronic myelogenous leukemia (CML).
Kataegis
A localized pattern of somatic genomic hypermutation in cancer cells defined by tight regional clusters of base substitutions occurring along a chromosome.
Multifactorial Inheritance
A pattern of inheritance governing complex traits and diseases resulting from the additive effects of multiple distinct genetic loci (polygenic) combined with non-genetic environmental influences without following classic Mendelian ratios.
Quantitative Traits
Complex phenotypes displaying continuous, measurable variation across a population that follow a bell curve distribution rather than discrete binary categories (e.g., height, blood pressure, weight).

Threshold Model
A conceptual framework explaining dichotomous multifactorial traits where continuous genetic and environmental liability is normally distributed, and the disease state is expressed only when liability exceeds a critical threshold.
Linkage
A specific biological relationship between two or more chromosomal loci that sit close together on the same chromosome and are co-inherited through meiotic events within pedigrees.
Association
A population-level statistical correlation where a particular allele or genetic variant co-occurs with a specific phenotypic trait or disease state significantly more frequently than would be expected by random chance (e.g., HLA-B27 with ankylosing spondylitis).
Genome-Wide Association Study (GWAS)
A hypothesis-free observational methodology that analyzes common single nucleotide polymorphisms (SNPs) across the entire genomes of large case and control cohorts to identify statistical associations with complex disease risks.